Core Laboratories N.V. (NYSE:CLB) is scheduled to post its quarterly earnings results after the market closes on Monday, July 24th. Analysts expect Core Laboratories N.V. to post earnings of $0.51 per share for the quarter. Core Laboratories N.V. has set its Q2 guidance at $0.48-0.52 EPS.

Core Laboratories N.V. (NYSE:CLB) last released its quarterly earnings data on Wednesday, April 19th. The oil and gas company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.03. Core Laboratories N.V. had a net margin of 11.10% and a return on equity of 43.28%. The company had revenue of $157.81 million during the quarter, compared to the consensus estimate of $150.44 million. During the same period in the previous year, the firm earned $0.37 earnings per share. Core Laboratories N.V.’s revenue for the quarter was up 2.7% on a year-over-year basis. On average, analysts expect Core Laboratories N.V. to post $2.13 EPS for the current fiscal year and $2.93 EPS for the next fiscal year.

Shares of Core Laboratories N.V. (CLB) opened at 106.34 on Monday. Core Laboratories N.V. has a 1-year low of $96.30 and a 1-year high of $127.82. The firm’s 50-day moving average is $103.76 and its 200 day moving average is $112.86. The stock has a market capitalization of $4.70 billion, a P/E ratio of 70.42 and a beta of 1.60.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 14th. Investors of record on Monday, July 17th will be given a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 2.07%. The ex-dividend date is Thursday, July 13th. Core Laboratories N.V.’s payout ratio is presently 145.70%.

ILLEGAL ACTIVITY WARNING: “Core Laboratories N.V. (CLB) Scheduled to Post Quarterly Earnings on Monday” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at

Several equities analysts recently weighed in on CLB shares. Scotiabank set a $133.00 price objective on shares of Core Laboratories N.V. and gave the company a “hold” rating in a research report on Wednesday, March 22nd. Loop Capital raised shares of Core Laboratories N.V. from a “hold” rating to a “buy” rating and raised their price objective for the company from $125.00 to $130.00 in a research report on Friday, April 21st. Zacks Investment Research lowered shares of Core Laboratories N.V. from a “buy” rating to a “hold” rating in a research report on Friday, June 23rd. BidaskClub lowered shares of Core Laboratories N.V. from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $130.00 price objective (down previously from $150.00) on shares of Core Laboratories N.V. in a research report on Wednesday, June 21st. Two analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $122.36.

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Earnings History for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with's FREE daily email newsletter.